2-Amino-5-Cbz-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine

Catalog No. :
ACXGZY517
CAS No. :
1141669-69-3
Molecular Formula :
C14H15N3O2S
Molecular Weight :
289.36

IUPAC Name:benzyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate

2-Amino-5-Cbz-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$238.00Login to see priceInquiryInquiry
1g95%$329.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-5-Cbz-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
IUPAC Namebenzyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
MDL No.A179561
Molecular FormulaC14H15N3O2S
Molecular Weight289.36
SMILESO=C(N1CCC2=C(SC(N)=N2)C1)OCC3=CC=CC=C3
InChI KeyWZTQWXKHLAJTRC-UHFFFAOYSA-N
Synonym1141669-69-3 | 2-Amino-5-Cbz-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine | 2-AMINO-5-CBZ-4,5,6,7-TETRAHYDRO-1,3-THIAZOLO[5,4-C]PYRIDINE | Benzyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate | benzyl 2-amino-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin
CAS No.1141669-69-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H320-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXGZY517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVLWZ149 route compound structure diagram
    --
  4. Then
  5. ACXGZY517 route product structure diagram
    ACXGZY5171141669-69-3
Inquiry

2. ACXGZY517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGZY517 route product structure diagram
    ACXGZY5171141669-69-3
Inquiry

Comments (0)